gmp

8stories

5 Maylast updated

Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries

Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries Curaleaf Laboratories today announced a significant milestone in the advancement of medical cannabis treatments in the United Kingdom, becoming the first licensed manufacturer in the country to develop and produce medical cannabis suppositories and pessaries.

BusinessOfCannabis5 May 2026

Medical

Could Colombian Cannabis Become the Next Big Thing in Europe?

3 February 2025

Opinion

The Maze Of Regulatory Requirements For Cannabis Medicinal Products In Europe – An Impression Of Scattered Regionalism, Associated With Risks For Patients

10 January 2023

Your #1 Podcast on Cannabis News

How to think about the emerging European CBD and cannabis markets

17 May 2021

More in gmp

Uncategorized
What Australian Good Manufacturing Practices certification means for Canadian cannabis
BofC Live is the daily news and interview program of Business of Cannabis.
BofC30 Nov
Your #1 Podcast on Cannabis News
Nick Pateras, Managing Director, Europe, Materia Ventures
Nick Pateras, the Managing Director, Europe for Materia Ventures joined BofC Live to talk about their entrance into both the UK and German markets. As well, Pateras discussed emerging European cannabis markets – including Malta. Listen to this episode as a podcast.
BofC14 May
Hemp Industry
Meet the Industry with Todd Palcic, President, Thar Process from MJBizCon 2019
At #MJBizCon2019, Business of Cannabis joined MNP, MGO Ello, Aird + Berlis and the Canadian Securities Exchange inside their Canada’s Cannabis Scene booth to conduct conversations about the state of the industry.
BofC24 Jan
Events
Medical Cannabis Week | Medical Cannabis and the International Market
BofC9 May

Sections

Data & Trackers

What’s On

More

gmp

Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries

Could Colombian Cannabis Become the Next Big Thing in Europe?

The Maze Of Regulatory Requirements For Cannabis Medicinal Products In Europe – An Impression Of Scattered Regionalism, Associated With Risks For Patients

How to think about the emerging European CBD and cannabis markets

More in gmp

What Australian Good Manufacturing Practices certification means for Canadian cannabis

Nick Pateras, Managing Director, Europe, Materia Ventures

Meet the Industry with Todd Palcic, President, Thar Process from MJBizCon 2019

Medical Cannabis Week | Medical Cannabis and the International Market